Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/11/2019
SIETES contiene 92834 citas

 
 
 1 a 20 de 58 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Jayadevappa R, Chhatre S, Malcowikz B, Parikh RB, Guzzo T, Wein AJ. Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer. JAMA Network Open 2019;2:e196562. [Ref.ID 103156]
2. Cita con resumen
Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association between androgen deprivation therapy and risk of dementia. JAMA Oncology 2016:13 de octubre. [Ref.ID 100814]
3. Cita con resumen
D'Amico AV, Chen M-H, Renshaw A, Loffredo M, Kantoff PW. Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA 2015;314:1291-3. [Ref.ID 99525]
4. Cita con resumen
Anónimo. Incontinences urinaires d'origine médicamenteuse. Prescrire 2015;35:271-4. [Ref.ID 99126]
5. Cita con resumen
Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gómez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens Jr FL, Gelber RD, Hortobagyi GN, Albain KS, for the POEMS/S0230 Investigators. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015;372:923-32. [Ref.ID 98930]
6. Cita con resumen
Johansson JE, Andrén O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO. Natural history of early, localized prostate cancer. JAMA 2014;291:2713-9. [Ref.ID 97706]
7. Cita con resumen
Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014;348:g129. [Ref.ID 97218]
8. Cita con resumen
Lapi F, Azoulay L, Niazi MT, Yin H, Benayoun S, Suissa S. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA 2013;310:289-96. [Ref.ID 95834]
9. Cita con resumen
Montastruc J-L. Médicaments et drogues à l'origine de dysfonctions érectiles. Bulletin d'Informations de Pharmacologie 2013;20:2. [Ref.ID 95184]
12.Tiene citas relacionadas Cita con resumen
Nguyen PL, Je Y, Schutz FAB, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trial. JAMA 2011;306:2359-66. [Ref.ID 91924]
13.Tiene citas relacionadas
Kelly WK, Gomella LG. Androgen deprivation therapy and competing risks. JAMA 2011;306:2382-3. [Ref.ID 91670]
14. Cita con resumen
Anónimo. Histréline. Nième agoniste de la gonadoréline, sans plus. Prescrire 2011;31:728. [Ref.ID 91595]
15.Tiene citas relacionadas
16.Tiene citas relacionadas Cita con resumen
Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M. Effect of gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 2011;306:269-76. [Ref.ID 90932]
17. Cita con resumen
Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Lelbenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, Shipley WU. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011;364:107-18. [Ref.ID 90831]
18. Cita con resumen
Anónimo. Agonistes de la GnRH: diabètes et troubles cardiaques. Prescrire 2011;31:272. [Ref.ID 90395]
19.
Anónimo. Degarelix (Firmagon) for prostate cancer. Med Lett Drugs Ther 2009;51:82-3. [Ref.ID 87348]
20. Cita con resumen
Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, for the ABCSG-12 Trial Investigators. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 2009;360:679-91. [Ref.ID 85243]
Seleccionar todas
 
 1 a 20 de 58 siguiente >>